Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Healthcare Editor
UK
23+ years of experience
In Vivo
By Ashley Yeo 28 Dec 2021
At the end of a turbulent year for health care, COVID-19 is still dominating the thoughts of stakeholders, but CMS patent attorneys Jane Hollywood and Rob Stephen are encouraged by the innovation and investment trends that are making it an exciting time to be in the thick of the action.
Medtech Insight
By Ashley Yeo 13 Aug 2021
There are just 4.5 months left until the new harmonized Eurasian Economic Union medtech system becomes mandatory, signifying major changes in regional market access. EAEU member Russia is meanwhile strengthening its post-market medtech controls.
Medtech Insight
By Ashley Yeo 23 Apr 2021
The UK’s new medical device registration system, one element of the post-Brexit transition being overseen by the MHRA, is going more or less to plan in the early stages of the standstill period.
Medtech Insight
By Ashley Yeo 27 Jan 2021
Government and industry in the UK are determined to make the best of the Brexit free trade deal, but German medtechs are eager for trade flow practicalities to be prioritized.
Topic Brexit Medtech-Brexit
Medtech Insight
By Ashley Yeo 27 Nov 2020
Germany’s authorities are back on guard against COVID-19 following renewed regional outbreaks. Diagnostics manufacturers will continue to play a strong part in bringing the pandemic substantially under control, a recent industry association virtual conference heard.
Medtech Insight
By Ashley Yeo 27 Nov 2020
Although the EU MDR and IVDR will fall outside the scope of new post-Brexit medtech regulations for Great Britain in 2021, the UK MHRA says it has the chance of developing its own world-leading regulatory regime.
Topic Medtech-Brexit Regulation Brexit
Medtech Insight
By Ashley Yeo 27 Nov 2020
ABHI director of value and access Luella Trickett talks about the importance of real-world evidence in product development and value-based procurement in secondary care in the UK.
Medtech Insight
By Ashley Yeo 23 Nov 2020
Incoming head of diagnostic regulation at the UK ABHI Steve Lee makes a plea for more detailed MHRA guidance around product registration requirements for the post-EU national market.
Topic Medtech-Brexit Regulation
Medtech Insight
By Ashley Yeo 23 Nov 2020
High level EU-UK negotiations have yet to deliver a free trade deal. Meanwhile, the MHRA has issued more guidance for medtechs accessing the UK market in 2021.
Topic EU Medtech-Brexit Brexit
Medtech Insight
By Ashley Yeo 23 Nov 2020
BVMed says the EU and the UK should set up a system of mutual recognition of medical device regulation to kick in when the UK’s EU exit transition period ends on 31 December.
Topic Medtech-Brexit Regulation Brexit
Medtech Insight
By Ashley Yeo 23 Nov 2020
The UK will have new regulatory systems for medical devices in place for when it leaves the EU at the end of this year. The Office for Life Sciences has been fielding more questions from industry on the new structures.
Topic Medtech-Brexit Regulation Brexit
Medtech Insight
By Ashley Yeo 23 Nov 2020
Taylor Wessing partner Alison Dennis and MHRA devices regulatory policy manager Gavia Taan provide updates on the UK’s device regulatory plans after the Brexit transition period ends.
Topic Medtech-Brexit Regulation Brexit
Medtech Insight
By Ashley Yeo 23 Nov 2020
The UK will have new regulatory systems for medical devices in place for when it leaves the EU at the end of this year. The Office for Life Sciences has been fielding more questions from industry on the new structures.
Topic Medtech-Brexit Regulation Brexit
Medtech Insight
By Ashley Yeo 21 Oct 2020
How coronavirus affects IVDs businesses depends on the branch of the industry they are in, a German survey of manufacturers shows. German labs performed one million COVID-19 tests last week.
Topic Coronavirus EU Policy & Regulation
Medtech Insight
By Ashley Yeo 09 Oct 2020
Coronavirus has diverted the focus of health systems away from early cancer detection, says a new report by Cancer Research UK, urging a rebalancing of priorities.
Topic Cancer Policy & Regulation
Medtech Insight
20 Jul 2022
Medtech Insight
20 Jul 2022
Medtech Insight
19 Jul 2022
In Vivo
13 Jul 2022
Medtech Insight
06 Jul 2022
Medtech Insight
27 Jun 2022
Medtech Insight
24 Jun 2022
Medtech Insight
23 Jun 2022
In Vivo
22 Jun 2022
Medtech Insight
22 Jun 2022
In Vivo
21 Jun 2022
Medtech Insight
17 Jun 2022
Medtech Insight
08 Jun 2022
Medtech Insight
01 Jun 2022
Medtech Insight
27 May 2022
